Overview
Dale C. Van Demark and Sarah T. Hogan will speak at Mergermarket’s Annual Life Sciences and Healthcare M&A Forum.
Topics will include:
- Exit opportunities for older fund vintages over the next 6-18 months
- Forecast 2017/18 dry powder deployment, sector economics and exit conditions
- When does private placement financing make sense? Prior to IPO or strategic sale?
- Challenges ahead in prepping portfolio companies for publicly traded life
- Considering recent product development failures and a thin product pipeline among biotech companies, how are portfolio managers positioning these investments?
STAY AHEAD OF THE CURVE
Interested in receiving articles on similar topics as they are published? Subscribe for timely email updates or contact us to discuss more…